Michael Wang

517 papers receiving 16.0k citations

Hit Papers

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials 2019 · 594 citations
5942007202620132019250500750

Peers

Michael Wang
Comparison fields: 5 of 166
  • Hematology 4.0k
  • Genetics 3.2k
  • Oncology 8.2k
  • Pathology and Forensic Medicine 4.8k
  • Immunology 2.6k
Replace Andrew W. Roberts with:
Andrew W. Roberts Australia
Robin Foà Italy
Richard Greil Austria
Govind Bhagat United States
Dieter Hoelzer Germany
Maher Albitar United States
Carlos E. Bueso‐Ramos United States
Edo Vellenga Netherlands
Philippe Moreau France
Giuseppe Leone Italy
Michael Wang relative to Andrew W. Roberts Australia Andrew W. Roberts's profile →
Citations per field
00.5×2.8×
Andrew W. Roberts · 1×
Citations per year

Countries citing papers authored by Michael Wang

Since Specialization
Citations

This map shows the geographic impact of Michael Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wang more than expected).

Fields of papers citing papers by Michael Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wang. The network helps show where Michael Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Wang Line = papers co-authored together Michael Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 554 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Hit paper breakdown →
2007925
2
T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
Hit paper breakdown →
2016596
3
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
Hit paper breakdown →
2019594
4
Seroepidemiology of Human Polyomaviruses
Hit paper breakdown →
2009570
5
Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol
Hit paper breakdown →
2009515
6 2004416
7 2005382
8 2008368
9 1999335
10 1998254
11 2009247
12 2007187
13 2008184
14 2016181
15 2014179
16 2010178
17 2010170
18 2014166
19 2020152
20 2019148

About Michael Wang

Michael Wang is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Immunology, having authored 554 papers that have together received 16.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (293 papers), Chronic Lymphocytic Leukemia Research (195 papers), CAR-T cell therapy research (107 papers), Multiple Myeloma Research and Treatments (103 papers), Viral-associated cancers and disorders (73 papers), Protein Degradation and Inhibitors (57 papers), Ubiquitin and proteasome pathways (33 papers) and Cancer Treatment and Pharmacology (28 papers). The work is most often cited by research in Hematology (4.0k citations), Genetics (3.2k citations), Oncology (8.2k citations), Pathology and Forensic Medicine (4.8k citations) and Immunology (2.6k citations). Michael Wang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Michael S. Brown, Joseph L. Goldstein, Rodney E. Infante, Hyock Joo Kwon, Jorge Romaguera, Preetesh Jain, Robert L. Garcea, Suchitra Rao, Larry W. Kwak and Luis Fayad. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Journal of Hematology & Oncology and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026